In New Lawsuit, Health Insurer Accuses Generic Drug Makers of Price-Fixing Conspiracy
October 16, 2019
MINNEAPOLIS — United Healthcare Services Inc. has sued several generic drug makers, accusing them of violating federal and state laws by conspiring to fix, increase, stabilize, or maintain prices of their drugs in order to avoid competing and keep prices high.
In 417-page complaint filed on Oct. 11 in the U.S. District Court for the District of Minnesota, UHS says the generic manufacturers “systematically communicated with one another directly to suppress competition and maintain anticompetitively high prices.”
The generic drug maker defendants include Teva Pharmaceuticals USA Inc., Actavis Pharma Inc., Apotex Corp., Dr. Reddy’s Laboratories Inc., Endo International PLC, Mylan …
- Boies Schiller Flexner
- Zelle LLP